We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TWG:NASDAQTop Wealth Group Holding Limited Analysis

Data as of 2026-06-19 - not real-time

$2.46

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Top Wealth Group is trading at $2.46, barely above its 30‑day support of $2.37 and well below all three moving averages (20‑day $2.67, 50‑day $3.11, 200‑day $4.42). The RSI of 34 signals an oversold condition while the MACD line has just crossed above its signal, offering a modest bullish hint. However, the stock sits in a sector with traditionally low cyclicality but exhibits extreme volatility (66.9% 30‑day) and a massive historical drawdown of ~89%, compounded by a negative beta that suggests it moves opposite to the market. Fundamentally, valuation metrics are ultra‑cheap (PE 0.64, PB 0.13, P/S 6.98) yet cash generation is weak – operating cash flow and free cash flow are deeply negative, and the company carries a modest debt load. No dividend is paid, and liquidity is thin with daily volume far below its 10‑day average. In short, the price is deeply discounted but the company’s cash‑flow profile and risk characteristics make any upside highly speculative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with limited upside cushion
  • Oversold RSI suggesting potential short‑term rebound
  • Increasing volume indicating some buying interest

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Extremely low valuation multiples relative to peers
  • Persistent negative operating and free cash flow
  • High volatility and historical drawdown limiting confidence

Long Term

> 3 years
Cautious
Model confidence: 3/10

Key Factors

  • Unsustainable cash‑flow profile and lack of profitability sustainability
  • Elevated liquidity risk due to thin trading volume
  • Continued exposure to high market and sector risk despite cheap price

Key Metrics & Analysis

Financial Health

Revenue Growth1326.40%
Profit Margin34.94%
P/E Ratio0.6
ROE13.76%
ROA8.10%
Debt/Equity0.84
P/B Ratio0.1
Op. Cash Flow$-6194419
Free Cash Flow$-7250085

Technical Analysis

TrendBearish
RSI34.5
Support$2.37
Resistance$3.04
MA 20$2.67
MA 50$3.11
MA 200$4.42
MACDBullish
VolumeIncreasing
Fear & Greed Index92.14

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.35
Volatility66.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.